In Brief: FDA immunosuppressant drugs subcommittee meeting
Executive Summary
FDA immunosuppressant drugs subcommittee meeting: On March 30, the subcommittee of the Antiviral Drugs Committee will discuss Syntex' NDAs for mycophenolate mofetil for prophylaxis of organ rejection and treatment of refractory organ rejection in patients receiving allogenic renal transplants. On March 31, the subcommittee will evaluate NDAs for Sandoz' cyclosporine microemulsion for prophylaxis of organ rejection in kidney, liver and heart allogenic transplants. The meeting will be held at the Silver Spring, Md. Holiday Inn, Plaza Ballroom, from 8 a.m.-6 p.m. on the first day and from 8 a.m.-2 p.m. on the second...